Uterine artery embolization for the treatment of symptomatic myomas in Brazilian women
Keywords:
Therapeutic embolization, Myoma, Uterine neoplasms, Uterine diseases, Treatment outcomeAbstract
CONTEXT: Uterine myomas are benign tumors that mostly occur in women of reproductive age at a frequency ranging from 20 to 25%. The symptoms are increased menstrual flow, pain and compressive signs. New treatments have been proposed and uterine artery embolization is one of them. OBJECTIVE: To evaluate the effects of treatment by embolization of the uterine artery, in women with symptomatic myomas. Uterine and dominant myoma volumes and the major symptoms were evaluated before treatment and 12 weeks later. TYPE OF STUDY: Open clinical trial. SETTING: A tertiary-care women’s hospital. PARTICIPANTS: The study was conducted on 32 women with symptomatic single or multiple myomas of the uterine body, seen at the outpatient unit from May 2000 to September 2001. MAIN MEASUREMENTS: The patients were submitted to gynecological examination and abdominal and endovaginal pelvic ultrasonography, and the examinations were repeated 12 weeks after the first procedure. Uterine artery embolization using PVA (polyvinyl alcohol) particles of 355-700 µ was performed by catheterization of the right femoral artery in 30 women and by bilateral catheterization in two. RESULTS: Before embolization, the mean uterine volume of the 32 women was 455 cm3 and the mean volume of the dominant myoma was 150 cm3. Twelve weeks after embolization, the mean uterine volume was 256 cm3 and the mean volume of the dominant myoma was 91 cm3, with p < 0.01 in both cases. Twelve weeks after the treatment, all the women answered a questionnaire, which showed that 71% had improvement in menstrual regularity, 90% decreased menstrual volume and 81% shortened menstrual duration. The most frequent immediate post-procedure symptoms, established as complications, were pain (100%) and fatigue (34%). One woman had myoma degeneration and was submitted to myomectomy. CONCLUSION: The significant reduction in uterine and dominant myoma volume confirms the validity of the treatment of symptomatic myomas by the technique of uterine artery embolization in Brazilian women. There was significant reduction in menstrual flow and duration, as well as better cycle regularity in the women studied. The few adverse effects observed in the sample studied mainly involved pain immediately after embolization.
Downloads
References
Brosens IA, Lunenfeld B, Donnez J. Pathogenesis and medical management of uterine fibroids. London: Parthenon Publish- ing Group; 1999.
Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990;94(4):435-8.
ACOG practice bulletin. Surgical alternatives to hysterectomy in the management of leiomyomas. Number 16, May 2000 (re- places educational bulletin number 192, May 1994). Int J Gynaecol Obstet 2001;73(3):285-93.
Gross CP, Anderson GF, Powe NR. The relation between fund- ing by the National Institutes of Health and the burden of dis- ease. N Engl J Med 1999;340(24):1881-7.
Chavez NF, Stewart EA. Medical treatment of uterine fibroids. Clin Obstet Gynecol 2001;44(2):372-84.
Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arte- rial embolisation to treat uterine myomata. Lancet 1995;346(8976):671-2.
Goodwin SC, Vedantham S, McLucas B, Forno AE, Perrella R. Preliminary experience with uterine artery embolization for uter- ine fibroids. J Vasc Interv Radiol 1997;8(4):517-26.
Worthington-Kirsch L, Walker WJ, Adler L, Hutchins Jr FL. Anatomic variation in the uterine arteries: a cause of failure of uterine artery embolisation for the management of symptomatic myomata. Min Invas Ther & Allied Technol 1998;8(6):397-402.
McLucas B, Adler L, Perrella R. Uterine fibroid embolization: nonsurgical treatment for symptomatic fibroids. J Am Coll Surg 2001;192(1):95-105.
Hurst BS, Stackhouse DJ, Matthews ML, Marshburn PB. Uter- ine artery embolization for symptomatic uterine myomas. Fertil Steril 2000;74(5):855-69.
Seldinger SI. Catheter replacement of needle in percutaneous arteriography. A new technique. Acta Radiol 1953;39:368-76.
Bradley EA, Reidy JF, Forman RG, Jarosz J, Braude PR. Transcatheter uterine artery embolisation to treat large uterine fibroids. Br J Obstet Gynaecol 1998;105(2):235-40.
Subramanian S, Clark MA, Isaacson K. Outcome and resource use associated with myomectomy. Obstet Gynecol 2001;98(4):583-7.
Worthington-Kirsch RL. Flow redistribution during uterine ar- tery embolization for the management of symptomatic fibroids. J Vasc Interv Radiol 1999;10(2 Pt 1):237-8.
Stringer NH, Grant T, Park J, Oldham L. Ovarian failure after uterine artery embolization for treatment of myomas. J Am Assoc Gynecol Laparosc 2000;7(3):395-400.
Spies JB, Roth AR, Gonsalves SM, Murphy-Skrzyniarz KM. Ovarian function after uterine artery embolization for leiomyo- mata: assessment with use of serum follicle stimulating hor- mone assay. J Vasc Interv Radiol 2001;12(4):437-42.
Pelage JP, Walker WJ, Le Dref O, et al. Treatment of uterine fibroids. Lancet 2001;357:(9267):1530.
Goodwin SC, McLucas B, Lee M, et al. Uterine artery emboli- zation for the treatment of uterine leiomyomata midterm re- sults. J Vasc Interv Radiol 1999;10(9):1159-65.
Spies JB, Warren EH, Mathias SD, Walsh SM, Roth AR, Pen- tecost MJ. Uterine fibroid embolization: measurement of health- related quality of life before and after therapy. J Vasc Interv Radiol 1999;10(10):1293-303.
Pelage JP, Le Dref O, Soyer P, et al. Fibroid-related menorrhagia: treatment with superselective embolization of the uterine arter- ies and midterm follow-up. Radiology 2000;215(2):428-31.
Ravina JH, Aymard A, Ciraru-Vigneron N, Ledreff O, Merland JJ. Embolisation artérielle des myomes utérins. J Gynecol Obstet Biol Reprod 2000;29(3):272-5.
Siskin GP, Englander M, Stainken BF, Ahn J, Dowling K, Dolen EG. Embolic agents used for uterine fibroid embolization. AJR Am J Roentgenol 2000;175(3):767-73.
Klein A, Schwartz ML. Uterine artery embolization for the treat- ment of uterine fibroids: an outpatient procedure. Am J Obstet Gynecol 2001;184(7):1556-60; discussion 1560-3.
Burn P, McCall J, Chinn R, Healy J. Embolization of uterine fibroids. Br J Radiol 1999;72(854):159-61.
Burn PR, McCall JM, Chinn RJ, Vashisht A, Smith JR, Healy JC. Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries. Radiology 2000;214(3):729-34.
Ravina JH, Bouret JM, Ciraru-Vigneron N, et al. Recourse to particular arterial embolization in the treatment of some uter- ine leiomyoma. Bull Acad Natl Med 1997;181(2):233-43; dis- cussion 244-6.
Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arte- rial embolisation to treat uterine myomata. Lancet 1995;346(8976):671-2.
Berkowitz RP, Hutchins FL, Worthington-Kirsch RL Vaginal expulsion of submucosal fibroids after uterine artery emboliza- tion. A report of three cases. J Reprod Med 1999;44(4):373-6.
Abbara S, Spies JB, Scialli AR, Jha RC, Lage JM, Nikolic B. Transcervical expulsion of a fibroid as a result of uterine artery embolization for leiomyomata. J Vasc Interv Radiol 1999;10(4):409-11.
Andersen PE, Lund N, Justesen P, Munk T, Elle B, Floridon C. Uterine artery embolization of symptomatic uterine fibroid. Initial success and short-term results. Acta Radiol 2001;42(2):234-8.
